A1L4Q6
Putative uncharacterized protein FLJ41423
Also known as: YK033_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for A1L4Q6 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
167 residues, UniProt reviewed canonical sequence.
>A1L4Q6|A1L4Q6
1 MAALSSRCPR SAAGPAYLQE AARSAHWASP PLVPLRTFQS SLFSSGSFHS REEEEEGVSL
61 LRTALVGQGP VPLFLGSLFC AGCRQGPSVW SCGEPVPRRI WVTASVTPSP RQALHPCSDS
121 LDILKALHLL PAAFSPFIWV QVFAEPSNKE SRGENDGGEE RESANIYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against A1L4Q6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads A1L4Q6 as an antibody target. Whether an autoantibody or antibody against A1L4Q6 could matter depends on whether native A1L4Q6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
A1L4Q6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label A1L4Q6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...